Glutamatergic and dopaminergic neurons in the mouse ventral tegmental area. 2015

Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
National Institutes of Health, National Institute on Drug Abuse, Intramural Research Program, Neuronal Networks Section, 251 Bayview Boulevard, Baltimore, MD, 21224, USA.

The ventral tegmental area (VTA) comprises dopamine (DA), γ-aminobutyric acid (GABA) and glutamate (Glu) neurons. Some rat VTA Glu neurons, expressing vesicular glutamate transporter 2 (VGluT2), co-express tyrosine hydroxylase (TH). While transgenic mice are now being used in attempts to determine the role of VGluT2/TH neurons in reward and neuronal signaling, such neurons have not been characterized in mouse tissue. By cellular detection of VGluT2 mRNA and TH immunoreactivity (TH-IR), we determined the cellular expression of VGluT2 mRNA within VTA TH-IR neurons in the mouse. We found that some mouse VGluT2 neurons coexpressed TH-IR, but their frequency was lower than in the rat. To determine whether low expression of TH mRNA or TH-IR accounts for this low frequency, we evaluated VTA cellular coexpression of TH transcripts and TH protein. Within the medial aspects of the VTA, some neurons expressed TH mRNA but lacked TH-IR; among them a subset coexpressed VGluT2 mRNA. To determine if lack of VTA TH-IR was due to TH trafficking, we tagged VTA TH neurons by Cre-inducible expression of mCherry in TH::Cre mice. By dual immunofluorescence, we detected axons containing mCherry, but lacking TH-IR, in the lateral habenula, indicating that low frequency of VGluT2 mRNA (+)/TH-IR (+) neurons in the mouse is due to lack of synthesis of TH protein, rather than TH protein trafficking. In conclusion, VGluT2 neurons are present in the rat and mouse VTA, but they differ in the populations of VGluT2/TH and TH neurons. Under normal conditions, the translation of TH protein is suppressed in the mouse mesohabenular TH neurons.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D005971 Glutamates Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure. Glutamic Acid Derivatives,Glutamic Acids,Glutaminic Acids
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014446 Tyrosine 3-Monooxygenase An enzyme that catalyzes the conversion of L-tyrosine, tetrahydrobiopterin, and oxygen to 3,4-dihydroxy-L-phenylalanine, dihydrobiopterin, and water. EC 1.14.16.2. Tyrosine Hydroxylase,3-Monooxygenase, Tyrosine,Hydroxylase, Tyrosine,Tyrosine 3 Monooxygenase
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D017557 Ventral Tegmental Area A region in the MESENCEPHALON which is dorsomedial to the SUBSTANTIA NIGRA and ventral to the RED NUCLEUS. The mesocortical and mesolimbic dopaminergic systems originate here, including an important projection to the NUCLEUS ACCUMBENS. Overactivity of the cells in this area has been suspected to contribute to the positive symptoms of SCHIZOPHRENIA. Area Tegmentalis Ventralis,Ventral Tegmental Area of Tsai,Area Tegmentalis Ventrali,Tegmental Area, Ventral,Tegmentalis Ventrali, Area,Tegmentalis Ventralis, Area
D050599 Vesicular Glutamate Transport Protein 2 A vesicular glutamate transporter protein that is predominately expressed in the DIENCEPHALON and lower brainstem regions of the CENTRAL NERVOUS SYSTEM. Vesicular Glutamate Transporter 2,DNPI Protein,Differentiation-Associated Na-Dependent Inorganic Phosphate Cotransporter,VGLUT2 Protein,Differentiation Associated Na Dependent Inorganic Phosphate Cotransporter

Related Publications

Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
April 2014, Sheng li ke xue jin zhan [Progress in physiology],
Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
January 2007, The European journal of neuroscience,
Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
January 2010, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
October 2014, The Journal of comparative neurology,
Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
June 2023, Journal of molecular neuroscience : MN,
Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
November 1999, Alcoholism, clinical and experimental research,
Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
August 2011, The Journal of physiology,
Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
June 2005, Life sciences,
Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
January 2009, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Tsuyoshi Yamaguchi, and Jia Qi, and Hui-Ling Wang, and Shiliang Zhang, and Marisela Morales
October 2000, Journal of neurochemistry,
Copied contents to your clipboard!